Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,040,531
+$171,876 QoQ
Shares Held
4,135
+3.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#2,499
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rosenberg Matthew Hamilton holds $5,886,852 across 15 Drug Manufacturers - General names. ABBV ranks #1 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
4,135 | $1,040,531 | |
| 2 | JNJ |
Johnson & Johnson
|
3,924 | $996,578 | |
| 3 | LLY |
ELI LILLY & Co
|
748 | $897,173 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,672 | $728,852 | |
| 5 | AMGN |
Amgen Inc
|
1,419 | $513,848 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,450 | $435,873 | |
| 7 | AZN |
Astrazeneca PLC
|
2,051 | $388,910 | |
| 8 | NVO |
Novo Nordisk A S
|
5,989 | $287,112 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,040,531 | 4,135 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $868,655 | 3,994 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $886,084 | 3,878 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $900,459 | 3,889 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $721,876 | 3,889 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $720,539 | 3,439 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $561,709 | 3,161 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $589,872 | 2,987 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $505,984 | 2,950 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $620,050 | 3,405 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $523,023 | 3,375 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $491,003 | 3,294 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $455,656 | 3,382 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $658,357 | 4,131 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $682,479 | 4,223 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $553,347 | 4,123 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $594,720 | 3,883 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $580,678 | 3,582 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $449,663 | 3,321 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $331,268 | 3,071 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $257,269 | 2,284 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $247,174 | 2,284 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $244,730 | 2,284 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $208,201 | 2,377 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $233,373 | 2,377 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $139,427 | 1,830 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||